The AI Sight Solution
AI Sight is a highly sensitive and specific, low-cost diagnostic tool capable of image interpretation across disease severity and treatment intervention points. It provides a clear identification of the confidence in each diagnosis and an integrated system for assessing borderline cases through human judgement.
The AI Sight Screening System
Backed by clinical trial data and a medical scientific team of some of the world’s foremost experts in DR diagnosis and treatment, our solution is a unique and highly flexible screening solution.
Our AI system compares each image of a patient’s retina against an existing library of diagnosed images to grade the presence and severity of diabetic retinopathy. The AI-Sight system is an inexpensive, web-based application that can be deployed globally.
In highly sophisticated healthcare settings, AI Sight performs the “heavy lifting” of high-volume image grading with higher accuracy and greater consistency than human graders, freeing up human capital to focus on borderline cases. In less sophisticated healthcare systems, it can be deployed as an end-to-end diabetic screening solution.
“Our mission is to take our unique AI approach to image interpretation from the lab bench to the global market, in support of diabetic patients and their clinical teams to ultimately reduce the societal impact of diabetes induced blindness.”
— Dr Steve Powell, Chief Executive Officer